Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

Guillain-Barré Syndrome is a rare neurological disorder where the body’s immune system—which normally protects it from ...

Celldex Therapeutics , Inc. (NASDAQ:CLDX), with a market capitalization of $1.72 billion, is a biopharmaceutical company focused on developing innovative therapies for challenging diseases, with its ...

Recent outbreak of Guillain–Barré syndrome in Pune causing panic, symptoms, diagnosis, treatment, and prevention explained in detail.

More than 86,000 recorded cases of respiratory syncytial virus in 2024 were in children younger than four years old.

Xencor has a strong cash position, bolstered by a recent $200 million secondary offering. Its pipeline has promise, but ...